(Q41136001)

27 September 2017

Conditioned place aversion following the central administration of a novel dopamine release inhibitor CGS 10746B (English)

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

29 October 2022

author name string

D. J. Calcagnetti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687164

29 October 2022

M. D. Schechter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687164

29 October 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

full work available at URL

27 September 2017

https://api.elsevier.com/content/article/PII:009130579190548G?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

https://api.elsevier.com/content/article/PII:009130579190548G?httpAccept=text/plain

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Pharmacology, Biochemistry and Behavior

29 October 2022

published in

1 reference

27 September 2017

40

1 reference

27 September 2017

255-259

1 reference

27 September 2017

2

1 reference

SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?

27 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

CGS 10746B: an atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses.

29 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Heroin reward is dependent on a dopaminergic substrate.

29 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release

29 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Flavor and location aversions produced by ethanol

29 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

In-vivo brain dialysis of neurotransmitters

29 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

29 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Injections of drugs into the lateral ventricle of the cat.

29 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Intracranial self-administration methodologies

29 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis

29 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

The use of place conditioning in studying the neuropharmacology of drug reinforcement.

29 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Pharmacological properties of the stimulant khat

29 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.

29 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination.

29 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Effect of learned behavior upon conditioned place preference to cathinone.

29 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Dopaminergic substrates of amphetamine-induced place preference conditioning.

29 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions.

29 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.

29 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Diazepam-induced place preference conditioning: appetitive and antiaversive properties.

29 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Restrained rats learn amphetamine-conditioned locomotion, but not place preference.

29 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Cholecystokinin produces conditioned place-aversions, not place-preferences, in food-deprived rats: evidence against involvement in satiety.

29 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Catecholamines and endogenous opioids in ventral tegmental self-stimulation reward.

29 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Microinjection of the dopamine antagonist cis-flupenthixol into the MPOA impairs copulation, penile reflexes and sexual motivation in male rats.

29 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

Presynaptic inhibition of nigrostriatal dopamine release in the mouse: Lack of cross tolerance between apomorphine, GBL and CGS 10746B

29 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90548-G

29 October 2022

Identifiers

1 reference

27 September 2017

1 reference